[NewYorkPost] Wegovy slashes risk of heart attack and stroke, drugmaker claims
Read Time:7 Second
The popular obesity medication successfully decreased the risk of major adverse cardiovascular events by 20% over a five year period, Novo Nordisk announced.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0